Bryan Garnier - WIRECARD AG (WDI) WIRECARD: Strong 2018; FY 2019 and mid-term guidance maintained | BUY - Top Picks | EUR240(+100%)

Report

Bryan Garnier

Richard-Maxime Beaudoux

WIRECARD: Strong 2018; FY 2019 and mid-term guidance maintained | BUY - Top Picks | EUR240(+100%)

WIRECARD - BUY - Top Picks | EUR240(+100%)
Strong 2018; FY 2019 and mid-term guidance maintained

2018 performance
2019 guidance confirmed
Visions 2020 and 2025 reiterated
We maintain our Buy â€“ Top Picks reco and FV of EUR240

25/04/2019 3 EN

Underlying

WIRECARD AG

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Richard-Maxime Beaudoux

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

Bryan Garnier

WIRECARD (SELL, FV Under Review) | End of coverage:

June 26, 2020 June 26, 2020 3 EN

Moody's Investors Service

Moody's withdraws Wirecard's ratings

Rating Action: Moody's withdraws Wirecard's ratings. Global Credit Research- 22 Jun 2020. Frankfurt am Main, June 22, 2020-- Moody's Investors Service, today withdrew Wirecard AG's B3 Corporate Family Rating, B3-PD Probability of Default Rating and the B3 instrument rating on the E500 million senior unsecured bond.

EUR 153.77

June 22, 2020 June 22, 2020 6 EN

Fastned: H1 results, GM recovery, roll-out acceleration expected in H2

This morning, Fastned published its H1 2025 key metrics and number of operating stations. H1 sales came in at EUR54.3m (+44% YoY), implying revenue of EUR26.3m in Q2 2025 (-9% vs cons. at EUR28.9m) and pointing to an annual run-rate of at least EUR108m (vs cons. at EUR130.8m for FY25 and STFe EUR13

August 14, 2025 August 14, 2025 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Avantium: financing package update

Yesterday, Avantium announced it had reached a conditional agreement with ABN AMRO, ASN, ING, Invest-NL and Rabobank to extend and amend its senior debt facility agreement, representing up to EUR125.1m as of December 2024. As such, (i) the remaining EUR14.1m debt commitment would be cancelled in ex

August 13, 2025 August 13, 2025 1 EN

Damien Choplain ... (+2)

Damien Choplain
Oscar Haffen Lamm

Valneva : Strong H1 - Key Lyme vaccine catalyst ahead in Q4

Valneva delivered a solid H1 and reaffirmed its 2025 guidance. The company’s cash position, standing at €161m, is sufficient to fund operations through 2027e, providing solid financial visibility. Looking ahead, the next key catalyst is the Phase III data readout for VLA15, Valneva’s Lyme disease v

August 12, 2025 August 12, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

WIRECARD: Strong 2018; FY 2019 and mid-term guidance maintained | BUY - Top Picks | EUR240(+100%)

Monthly LMI Update Independent Investment Research

WIRECARD (SELL, FV Under Review) | End of coverage:

Moody's withdraws Wirecard's ratings

Fastned: H1 results, GM recovery, roll-out acceleration expected in H2

Avantium: financing package update

Valneva : Strong H1 - Key Lyme vaccine catalyst ahead in Q4

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe